مورد إلكتروني

Diagnosis and treatment of Friedreich ataxia: a European perspective.

التفاصيل البيبلوغرافية
العنوان: Diagnosis and treatment of Friedreich ataxia: a European perspective.
المصدر: Nature reviews. Neurology, 5 (4
بيانات النشر: 2009-04
تفاصيل مُضافة: Schulz, Jörg Bernhard
Boesch, S
Bürk, Katrin
Dürr, Alexandra
Giunti, P
Mariotti, Christian
Pousset, Francoise
Schöls, Lüdger
Vankan, Pierre
Pandolfo, Massimo
نوع الوثيقة: Electronic Resource
مستخلص: Friedreich ataxia is the most frequent hereditary ataxia, with an estimated prevalence of 3-4 cases per 100,000 individuals. This autosomal-recessive neurodegenerative disease is characterized by progressive gait and limb ataxia, dysarthria, lower-limb areflexia, decreased vibration sense, muscular weakness in the legs, and a positive extensor plantar response. Non-neurological signs include hypertrophic cardiomyopathy and diabetes mellitus. Symptom onset typically occurs around puberty, and life expectancy is 40-50 years. Friedreich ataxia is usually caused by a large GAA-triplet-repeat expansion within the first intron of the frataxin (FXN) gene. FXN mutations cause deficiencies of the iron-sulfur cluster-containing subunits of the mitochondrial electron transport complexes I, II, and III, and of the iron-sulfur protein aconitase. Mitochondrial dysfunction has been addressed in several open-label, non-placebo-controlled trials, which indicated that treatment with idebenone might ameliorate hypertrophic cardiomyopathy; a well-designed phase II trial suggested concentration-dependent functional improvements in non-wheelchair-bound children and adolescents. Other current experimental approaches address iron-mediated toxicity, or aim to increase FXN expression through the use of erythropoietin and histone deacetylase inhibitors. This Review provides guidelines, from a European perspective, for the diagnosis of Friedreich ataxia, differential diagnosis of ataxias and genetic counseling, and treatment of neurological and non-neurological symptoms.
Journal Article
Review
info:eu-repo/semantics/published
مصطلحات الفهرس: Sciences bio-médicales et agricoles, Antioxidants -- therapeutic use, Diagnosis, Differential, Diagnostic Imaging, Europe -- epidemiology, Friedreich Ataxia -- diagnosis, Friedreich Ataxia -- epidemiology, Friedreich Ataxia -- genetics, Friedreich Ataxia -- therapy, Humans, Muscle, Skeletal -- physiopathology, Neurophysiology -- methods, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/51515
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
الإتاحة: Open access content. Open access content
ملاحظة: No full-text files
English
أرقام أخرى: EQY oai:dipot.ulb.ac.be:2013/51515
uri/info:doi/10.1038/nrneurol.2009.26
uri/info:pii/nrneurol.2009.26
uri/info:pmid/19347027
uri/info:scp/67649213875
764593275
المصدر المساهم: UNIVERSITE LIBRE DE BRUXELLES
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.ocn764593275
قاعدة البيانات: OAIster